ArticleAging cell2026
iLDA-SGCN: Identifying Associations Between Age-Related Diseases and Long Non-Coding RNAs Using Dual Graph Convolutional Networks.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Aging reshapes global disease burdens, yet the regulatory roles of long non-coding RNAs (lncRNAs) in age-related disorders remain incompletely characterized. We developed iLDA-SGCN, a graph-based computational framework that integrates singular value decomposition (SVD) with dual graph convolutional networks (GCNs) to predict lncRNA-disease associations. SVD first derives compact low-dimensional representations from the lncRNA-disease association matrix. Two complementary GCN modules then learn topology-aware embeddings: a correlation-map GCN operating on the bipartite lncRNA-disease network, and a similarity-map GCN operating on fused homogeneous graphs of lncRNAs and diseases constructed from MeSH semantic similarity and Gaussian association-profile kernels. Finally, association scores are estimated with an inner-product decoder optimized with a class-imbalance-aware loss function. Across five-fold cross-validation on LncRNADisease and MNDR datasets, iLDA-SGCN outperformed five competitive methods (SDLDA, LDNFSGB, IPCARF, LDASR, and LDA-VGHB) in terms of AUC (area under the ROC curve) and AUPR (area under the precision-recall curve). The model achieved AUC/AUPR of 0.960/0.968 on MNDR and 0.896/0.901 on LncRNADisease, with only a marginal precision shortfall versus LDA-VGHB on LncRNADisease. Ablation studies showed both GCN modules improved over a fully connected backbone, with the similarity-map GCN contributing the largest gains; the full model performed best overall. In case studies across eight prototypical age-related diseases, iLDA-SGCN identified HOTAIR, MALAT1, PVT1, MEG3, H19, LSINCT5, UCA1, and other candidates, yielding 33 candidates potentially involved in age-related disease mechanisms that require further experimental validation. Collectively, iLDA-SGCN integrates semantic and topological information to prioritize candidate lncRNA-disease associations related to aging, providing testable hypotheses for downstream mechanistic studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.